102 related articles for article (PubMed ID: 38129228)
1. Female-specific pancreatic cancer survival from CT imaging of visceral fat implicates glutathione metabolism in solid tumors.
Ballard DH; Nguyen GK; Atagu N; Camps G; Salter A; Jaswal S; Naeem M; Ludwig DR; Mellnick VM; Peterson LR; Hawkins WG; Fields RC; Luo J; Ippolito JE
Acad Radiol; 2023 Dec; ():. PubMed ID: 38129228
[TBL] [Abstract][Full Text] [Related]
2. Synergy of Sex Differences in Visceral Fat Measured with CT and Tumor Metabolism Helps Predict Overall Survival in Patients with Renal Cell Carcinoma.
Nguyen GK; Mellnick VM; Yim AK; Salter A; Ippolito JE
Radiology; 2018 Jun; 287(3):884-892. PubMed ID: 29558292
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in abdominal visceral fat composition and metabolism as predictors of DLBCL prognosis: A retrospective cohort study.
Wang L; Zhang S; Xin J
Eur J Radiol; 2024 Jan; 170():111205. PubMed ID: 38000332
[TBL] [Abstract][Full Text] [Related]
4. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade.
Hu Z; Wu J; Lai S; Xu Y; Zhan J; Li R; Liu X; Wang N; Wei X; Jiang X; Yang R
Eur Radiol; 2020 Jul; 30(7):3977-3986. PubMed ID: 32144457
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
Jaswal S; Sanders V; Pullarkat P; Teja S; Salter A; Watkins MP; Atagu N; Ludwig DR; Mhlanga J; Mellnick VM; Peterson LR; Bartlett NL; Kahl BS; Fehniger TA; Ghobadi A; Cashen AF; Mehta-Shah N; Ippolito JE
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740596
[TBL] [Abstract][Full Text] [Related]
6. The value of sex-specific abdominal visceral fat as measured via CT as a predictor of clear renal cell carcinoma T stage.
Guo H; Zhao W; Wang A; Li M; Ma H; Wang F; Wang Q; Ba X
Adipocyte; 2021 Dec; 10(1):285-292. PubMed ID: 34014795
[TBL] [Abstract][Full Text] [Related]
7. Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer.
Ke ZB; Chen H; Chen JY; Cai H; Lin YZ; Sun XL; Huang JB; Zheng QS; Wei Y; Xue XY; Xu N
Clin Nutr; 2021 Dec; 40(12):5792-5801. PubMed ID: 34775222
[TBL] [Abstract][Full Text] [Related]
8. Imaging-Based Subtypes of Pancreatic Ductal Adenocarcinoma Exhibit Differential Growth and Metabolic Patterns in the Pre-Diagnostic Period: Implications for Early Detection.
Zaid M; Elganainy D; Dogra P; Dai A; Widmann L; Fernandes P; Wang Z; Pelaez MJ; Ramirez JR; Singhi AD; Dasyam AK; Brand RE; Park WG; Rahmanuddin S; Rosenthal MH; Wolpin BM; Khalaf N; Goel A; Von Hoff DD; Tamm EP; Maitra A; Cristini V; Koay EJ
Front Oncol; 2020; 10():596931. PubMed ID: 33344245
[TBL] [Abstract][Full Text] [Related]
9. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
Cheng SH; Cheng YJ; Jin ZY; Xue HD
Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Evaluation of Treatment Response in Patients with Nonmetastatic Pancreatic Cancer Using CT and CA 19-9.
Kim SS; Lee S; Lee HS; Bang S; Han K; Park MS
Radiology; 2022 Jun; 303(3):548-556. PubMed ID: 35258374
[TBL] [Abstract][Full Text] [Related]
11. High visceral fat attenuation and long-term mortality in a health check-up population.
Lee JH; Choi SH; Jung KJ; Goo JM; Yoon SH
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1495-1507. PubMed ID: 37016984
[TBL] [Abstract][Full Text] [Related]
12. LDHA is a prognostic biomarker on the immune response in pancreatic adenocarcinoma and associated with m6A modification.
Tan Z; Liu J; Xu J; Zhang B; Yu X; Wang W; Liang C
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4853-4865. PubMed ID: 36269388
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
[No Abstract] [Full Text] [Related]
15. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma.
Cai W; Bao W; Chen S; Yang Y; Li Y
Cancer Cell Int; 2021 Dec; 21(1):698. PubMed ID: 34930261
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative [
Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
[TBL] [Abstract][Full Text] [Related]
17. Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma.
Mathur A; Hernandez J; Shaheen F; Shroff M; Dahal S; Morton C; Farrior T; Kedar R; Rosemurgy A
HPB (Oxford); 2011 Jun; 13(6):404-10. PubMed ID: 21609373
[TBL] [Abstract][Full Text] [Related]
18. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
[TBL] [Abstract][Full Text] [Related]
19. Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.
Liu H; Naxerova K; Pinter M; Incio J; Lee H; Shigeta K; Ho WW; Crain JA; Jacobson A; Michelakos T; Dias-Santos D; Zanconato A; Hong TS; Clark JW; Murphy JE; Ryan DP; Deshpande V; Lillemoe KD; Fernandez-Del Castillo C; Downes M; Evans RM; Michaelson J; Ferrone CR; Boucher Y; Jain RK
Clin Cancer Res; 2017 Oct; 23(19):5959-5969. PubMed ID: 28600474
[No Abstract] [Full Text] [Related]
20. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
